Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

Journal Title: UNKNOWN - Year 2019, Vol 25, Issue 1

Abstract

.

Authors and Affiliations

Faruk Uğur Doğan, Murat Kürtüncü

Keywords

Related Articles

Correlation of Prechtl Qualitative Assessment of General Movement Analysis with Neurological Evaluation: The Importance of Inspection in Infants

Objective: Motor development is at the forefront of evaluation of neurodevelopmental functions in the first 6 months of life. Significant spontaneous movement patterns of infants are called general movements. General mov...

The Assesment of Efficacy of Traditional and Complementary Medicine Practices in Neurology

Traditional, complementary, and alternative medicine practices are used in the prevention, diagnosis, and treatment of a wide variety of diseases in the world. Such practices in Turkey are regulated by the “Regulation of...

Seizures with Autonomic Symptoms and Sudden Unexpected Death in Epilepsy (SUDEP)

The autonomic nervous system, formerly the vegetative nervous system, is a division of the peripheral nervous system that supplies smooth muscle and glands, and thus influences the function of internal organs. The hypoth...

Factors Associated with Prognosis in Patients with Guillain-Barré Syndrome

Objective: We aimed to evaluate the demographic, clinical, laboratory and electrophysiological findings of patients with inpatient Guillain-Barré syndrome in our clinics and to investigate the effect of these parameters...

Download PDF file
  • EP ID EP539584
  • DOI 10.4274/tnd.galenos.2019.57224
  • Views 69
  • Downloads 0

How To Cite

Faruk Uğur Doğan, Murat Kürtüncü (2019). Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis. UNKNOWN, 25(1), 52-53. https://europub.co.uk./articles/-A-539584